Bullish for Exports: India-US Trade Deal "99% Done" - IT, Pharma to

US Ambassador Sergio Gor announced that the India-US trade agreement is "99% there" and nearing finalization, with only the last 1% of technical details being worked out. He is meeting with Union Commerce Minister Piyush Goyal to discuss the pact.

A comprehensive trade agreement between India and the US, two of the world's largest economies, would significantly reduce trade barriers and foster greater economic cooperation. This is a major positive catalyst for Indian companies involved in exports to the US, potentially boosting their revenues and market share.

Sectors like IT services (e.g., TCS, INFY, HCLTECH), pharmaceuticals (e.g., SUNPHARMA, DRREDDY, CIPLA), and potentially textiles and certain manufacturing segments could see a positive impact. Improved market access and potentially reduced tariffs would enhance their competitiveness and profitability.

Traders should closely watch for the official announcement of the trade agreement and its specific terms, particularly regarding tariff reductions and market access for key Indian export sectors. This will provide clearer direction on which companies stand to benefit the most.

• •India-US trade agreement "99% there"
• •Last 1% being finalized
• •US Ambassador Sergio Gor revealed the status
• •Ambassador Gor meeting Union Commerce Minister Piyush Goyal
• •Risk flag: Unexpected last-minute hurdles in finalization